Lynn McFadyen

836 total citations
39 papers, 634 citations indexed

About

Lynn McFadyen is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lynn McFadyen has authored 39 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Virology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lynn McFadyen's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (9 papers). Lynn McFadyen is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (9 papers). Lynn McFadyen collaborates with scholars based in United Kingdom, United States and South Africa. Lynn McFadyen's co-authors include B.C. Weatherley, Phylinda L. S. Chan, Jennifer Smit, Philippe Jacqmin, Khangelani Zuma, Mags Beksinska, Julia Botha, Marc Lavielle, Mats O. Karlsson and E. Niclas Jonsson and has published in prestigious journals such as Social Science & Medicine, Antimicrobial Agents and Chemotherapy and Pharmaceutical Research.

In The Last Decade

Lynn McFadyen

38 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn McFadyen United Kingdom	16	227	153	129	116	104	39	634
Douglas Shaffer United States	14	260 1.1×	64 0.4×	83 0.6×	77 0.7×	186 1.8×	30	774
R. Chris Rathbun United States	15	424 1.9×	172 1.1×	89 0.7×	51 0.4×	235 2.3×	35	729
Patrick G. Clay United States	15	346 1.5×	134 0.9×	35 0.3×	80 0.7×	183 1.8×	41	791
Christine Sekaggya‐Wiltshire Uganda	14	341 1.5×	58 0.4×	45 0.3×	39 0.3×	231 2.2×	67	638
Baba Maiyaki Musa Nigeria	13	225 1.0×	79 0.5×	74 0.6×	75 0.6×	350 3.4×	57	831
Francesca Rocchi Italy	12	144 0.6×	164 1.1×	231 1.8×	55 0.5×	116 1.1×	26	752
Rada Savic United States	18	823 3.6×	185 1.2×	147 1.1×	187 1.6×	478 4.6×	49	1.4k
John Rublein United States	10	296 1.3×	128 0.8×	66 0.5×	23 0.2×	104 1.0×	15	502
C. William Wester United States	14	263 1.2×	122 0.8×	46 0.4×	39 0.3×	192 1.8×	29	553
Megan Turner United States	14	637 2.8×	306 2.0×	32 0.2×	23 0.2×	199 1.9×	39	910

Countries citing papers authored by Lynn McFadyen

Since Specialization

Citations

This map shows the geographic impact of Lynn McFadyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn McFadyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn McFadyen more than expected).

Fields of papers citing papers by Lynn McFadyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn McFadyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn McFadyen. The network helps show where Lynn McFadyen may publish in the future.

Co-authorship network of co-authors of Lynn McFadyen

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn McFadyen. A scholar is included among the top collaborators of Lynn McFadyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn McFadyen. Lynn McFadyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Das, Shampa, Todd Riccobene, Timothy J. Carrothers, et al.. (2024). Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation. European Journal of Clinical Pharmacology. 80(4). 529–543. 11 indexed citations

Wright, James G., et al.. (2019). A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators. Infectious Diseases and Therapy. 8(2). 185–198. 16 indexed citations

Smith, Michael K., Kaori Ito, E. Niclas Jonsson, et al.. (2018). PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting Workflow. The AAPS Journal. 20(3). 52–52. 4 indexed citations

Weatherley, B.C., et al.. (2017). Population Pharmacokinetics of Fosdagrocorat (PF‐04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis. Clinical and Translational Science. 11(1). 54–62. 6 indexed citations

Vourvahis, Manoli, et al.. (2013). Pharmacokinetics, Safety, and Tolerability of Maraviroc in HIV-Negative Subjects with Impaired Renal Function. HIV Clinical Trials. 14(3). 99–109. 10 indexed citations

Mills, Anthony, Donna Mildvan, Daniel Podzamczer, et al.. (2012). Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(2). 164–170. 30 indexed citations

Chan, Phylinda L. S., Philippe Jacqmin, Marc Lavielle, Lynn McFadyen, & B.C. Weatherley. (2010). The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects. Journal of Pharmacokinetics and Pharmacodynamics. 38(1). 41–61. 61 indexed citations

Jacqmin, Philippe, Lynn McFadyen, & Janet R. Wade. (2010). Basic PK/PD principles of drug effects in circular/proliferative systems for disease modelling. Journal of Pharmacokinetics and Pharmacodynamics. 37(2). 157–177. 14 indexed citations

Weatherley, B.C. & Lynn McFadyen. (2009). Maraviroc modelling strategy: use of early phase 1 data to support a semi‐mechanistic population pharmacokinetic model. British Journal of Clinical Pharmacology. 68(3). 355–369. 5 indexed citations

10.

Fätkenheuer, Gerd, Schlomo Staszewski, Frances Hackman, et al.. (2009). Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients. AIDS. 23(16). 2115–2122. 34 indexed citations

11.

Tunblad, Karin, Lars Lindbom, Lynn McFadyen, et al.. (2008). The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data. Journal of Pharmacokinetics and Pharmacodynamics. 35(5). 503–526. 27 indexed citations

12.

Jacqmin, Philippe, Lynn McFadyen, & Janet R. Wade. (2008). A receptor theory‐based semimechanistic PD model for the CCR5 noncompetitive antagonist maraviroc. British Journal of Clinical Pharmacology. 65(s1). 95–106. 10 indexed citations

13.

Chan, Phylinda L. S., B.C. Weatherley, & Lynn McFadyen. (2008). A population pharmacokinetic meta‐analysis of maraviroc in healthy volunteers and asymptomatic HIV‐infected subjects. British Journal of Clinical Pharmacology. 65(s1). 76–85. 27 indexed citations

14.

Claret, Laurent, Eugène Cox, Lynn McFadyen, et al.. (2006). Modeling and Simulation of Sexual Activity Daily Diary Data of Patients with Female Sexual Arousal Disorder Treated with Sildenafil Citrate (Viagra®). Pharmaceutical Research. 23(8). 1756–1764. 12 indexed citations

15.

Smit, Jennifer, Julia Botha, Lynn McFadyen, & Mags Beksinska. (2004). Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval. Contraception. 69(1). 3–7. 24 indexed citations

16.

Kowalski, Kenneth G., et al.. (2003). A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data. Journal of Pharmacokinetics and Pharmacodynamics. 30(5). 315–336. 30 indexed citations

17.

Jonsson, E. Niclas, Saila Antila, Lynn McFadyen, Lasse Lehtonen, & Mats O. Karlsson. (2003). Population pharmacokinetics of levosimendan in patients with congestive heart failure. British Journal of Clinical Pharmacology. 55(6). 544–551. 33 indexed citations

18.

Smit, Jennifer, Lynn McFadyen, Khangelani Zuma, & Eleanor Preston‐Whyte. (2002). Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa. Social Science & Medicine. 55(9). 1511–1522. 32 indexed citations

19.

McFadyen, Lynn, et al.. (2001). Emergency contraception in South Africa: knowledge, attitudes, and use among public sector primary healthcare clients. Contraception. 64(6). 333–337. 38 indexed citations

20.

Moodley, Jagidesa, et al.. (1992). The efficacy of phenytoin in relation to serum levels in severe pre‐eclampsia and eclampsia. BJOG An International Journal of Obstetrics & Gynaecology. 99(11). 881–886. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact